Why the study?
Hepatitis C is often detected too late for efficient treatment, necessitating a highly sensitive and selective screening system for early detection.
This review highlights recent advancements in highly sensitive electrochemical screening methods for early detection of Hepatitis C virus.
May aid earlier HCV diagnosis in at-risk groups; leaves open prospective validation before routine use.
Hepatitis C virus is very common amongst population infected with viral hepatitis. A very important point before deciding on the correct treatment is the stage of illness. More people are detected too late, and therefore the treatment was not efficient. A highly sensitive and selective screening system for early detection is needed in order to cure the patient cured. Therefore, this review is summarizing new methods of detection of specific biomarkers/genotypes for viral hepatitis C, to help find the highest sensitive screening methods that may influence the decision of the most efficient treatment.
No takes yet. Share an insight, caveat, or question.
Ilie‐Mihai et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: